RECOVERY & REPAIR
BPC-157
Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.
From $179/mo
Nasal spray
Glutathione Nasal Spray
Compounded glutathione nasal spray for a no-needle route designed to fit more naturally into the treatment routine.
Your treatment plan
From $89/month equivalent
$267 billed every 3 months3-month commitment$119 billed monthly also availableAll fees includedView plan details
- Licensed clinicians
- Compounded by a licensed 503A pharmacy
- No clinic visit
Questions before you start?
Compare this treatmentWhat will I pay?
Standard plan price$89 per month equivalent, billed $267 every 3 months. 3-month commitment.
Billing options and renewal
The standard Glutathione Nasal Spray price is $119 billed monthly, or $267 paid up front every three months ($89 per month equivalent; a three-month commitment). These are recurring prices before any eligible first-order discount. A first-order offer reduces that order only; renewal uses the standard price for the chosen plan. A monthly equivalent is not a monthly charge.
What should I know about this treatment?
Compounded glutathione nasal spray for a no-needle route designed to fit more naturally into the treatment routine.
Read the evidence and its limitationsWhat should I review before starting?
A licensed clinician reviews your health history and medications and determines whether treatment is appropriate for you.
Read the full Important Safety InformationHow do I request Glutathione Nasal Spray online?
Complete the online assessment with your health history, current medications and treatment goals. A licensed clinician reviews the information and decides whether to prescribe. If prescribed, a licensed pharmacy prepares and ships your medication.
See how care worksWhat It Is
Same endogenous molecule. A very different routine.
Glutathione is a three-amino-acid molecule your own cells make and use in normal antioxidant defense. Its biology is not exotic. The format is the distinction.
This preparation is delivered as a nasal spray rather than an injection.
The nasal lining offers a non-oral, needle-free route, which can make the practical experience of treatment dramatically simpler for someone who does not want injections in the routine. That does not mean the spray should be treated as automatically equivalent to injectable glutathione. Route matters, and your provider decides whether this formulation makes sense for the reason you are considering treatment.
The science underneath the molecule stays the same: glutathione participates in neutralizing reactive molecules as part of ordinary cellular antioxidant chemistry. That mechanism does not establish outcomes for detoxification, aging, immunity, or energy.
Absorption is the central question. If you are looking beyond generic detox language, the nasal route deserves form-specific logic and practical expectations.
Read the evidenceWho It's For
For people who like the molecule more than the needle.
01
The Needle-Averse
You are interested in clinician-guided glutathione but know an injection routine is not one you are likely to keep. A nasal format makes the practical question easier.
02
The Mechanism-First Patient
You want the antioxidant biology without the cleanse narrative. Glutathione already has a legitimate endogenous role, which is enough to discuss without inflating it.
03
The Simplicity Seeker
You know adherence gets worse when a routine becomes a project. A nasal spray is a smaller daily ask, provided your clinician determines the route fits your case.
Compounded glutathione nasal spray is not an FDA-approved drug product. A licensed provider sets candidacy and cadence from your full intake, and results vary.
This might not be the right fit if:
- Active nasal or sinus infection, recent nasal surgery, or significant nasal polyps
- Known hypersensitivity to glutathione or any component of the formulation
- Asthma or reactive airway disease, given reports of bronchospasm with inhaled glutathione
- Pregnancy or breastfeeding, where safety data are insufficient
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Your Plan
Glutathione Nasal Spray, prescribed with care.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
- Format
- Nasal spray
- Strength
- 200 mg/mL
- Total plan quantity
- 3 x 30 mL
- Billed amount
- $267 every 3 months
- Monthly equivalent
- $89 per month
- Commitment
- 3 months
- Monthly option
- $119 billed monthly · 30 mL total plan quantity
- Fees
- Included in the plan price
Strength describes the preparation. Total plan quantity is the amount included in that plan, not your dose or dosing schedule. Follow the directions on your prescription.
Compare billing options and longer-term costs
Compounded by a licensed 503A pharmacy
Glutathione Nasal Spray
Nasal spray
From $89
Monthly equivalent. All fees included.
$267 billed every 3 months. 3-month commitment.
- Compounded glutathione delivered as a needle-free nasal spray
- Endogenous antioxidant biology described at mechanism level, not as a promised outcome
- Schedule set after clinician review
- Prepared by a licensed 503A pharmacy to your individual prescription
- Response and tolerability reviewed through ongoing care
$89 /mo equivalent · 3-month commitment
$89/mo equivalent, all-in. Consultation is included in the plan price, not added on top. Consultation, cancellation and refund policy.
What happens when I start?
You'll begin an online assessment for Glutathione Nasal Spray.
- Tell your clinician about you. Share your goals, health history and current medications.
- Review your plan. Confirm the treatment option, billing interval and total shown in the assessment.
- Get an individual clinical review. Your clinician decides whether to prescribe. If prescribed, a licensed pharmacy fulfills your prescription.
Starting an assessment doesn't guarantee a prescription. How care works
Prescription issued subject to provider judgment. Results vary. Not a guarantee of outcomes.
*Price reflects a 3-month commitment. See billing details above.
Your subscription renews at your selected billing interval. Cancel through your member dashboard before the next billing date to stop future charges. Cancellation does not refund the current billing period. See cancellation and refund terms.
Have a question about this plan?
Clinical questions
Message your provider about dosing, side effects, your response or changes in your health.
Open patient portalNew to AnthologyRX? Ask our team about getting started.
The people behind your care
Guidance from the first question onward.
Independent clinical care
Licensed clinicians affiliated with Arora Health & Aesthetics, LLC review your health history, medications and goals, then discuss whether Glutathione Nasal Spray or another approach fits your needs.
Medical information on this page reviewed by Dr. Dylan Russell, MD, Chief Health Officer on . Your prescribing clinician provides your individual care.
Verify Dr. Russell's medical licensePharmacy quality that matters
Prepared to your prescription by a licensed compounding pharmacy. Our partners have verified quality programs covering identity, potency, independent testing and batch documentation.
Compounded preparations are not FDA-approved. Pharmacy quality controls and your clinician's evaluation of treatment evidence each have a role in your care.
Pharmacy & fulfillment
Listed dispensing pharmacy
- The Pharmacy Hub LLCFormulation: Glutathione Nasal SprayVerify: Florida pharmacy license PH33959
Availability depends on your prescription and location. For pharmacy questions, contact our team.
A direct line for follow-up
Message your provider through the patient portal about dosing, side effects, your response or changes in your health. Contact AnthologyRX support for billing, shipment or portal-access help.
The Evidence
What the research shows
Intranasal glutathione was tolerated, with no substantial difference in adverse events.
30 people
randomized to intranasal placebo, 300 mg or 600 mg per day
The detail
In a randomized, double-blind trial, 30 people with Parkinson disease received intranasal placebo, 300 mg per day, or 600 mg per day of reduced glutathione in three divided daily doses for three months. There were no substantial differences between groups in the number of adverse events reported or observed, and all groups met the trial’s tolerability criteria.1
Every group improved, including placebo; neither glutathione dose beat placebo.
4.6 points
gain on the total Unified Parkinson Disease Rating Scale in the 200 mg group
The detail
In a double-blind, placebo-controlled Phase IIb trial, 45 people with Hoehn and Yahr Stage 1 to 3 Parkinson disease received intranasal placebo, 100 mg, or 200 mg of reduced glutathione three times daily for three months. Every group improved, including placebo; the 200 mg group improved on the total Unified Parkinson Disease Rating Scale by 4.6 points over baseline; neither glutathione dose was superior to placebo; and one participant in the 200 mg group developed cardiomyopathy.2
A single intranasal dose raised brain glutathione above baseline for about an hour.
Above baseline
brain glutathione after a single 200 mg intranasal dose, measured by magnetic resonance spectroscopy
The detail
In 15 participants with mid-stage Parkinson disease, a single 200 mg intranasal dose of reduced glutathione raised brain glutathione measured by magnetic resonance spectroscopy above baseline. The increase was not detectable eight minutes after administration but was present at every later time point across approximately one hour of measurement.3
Intravenous glutathione was tolerated but did not change symptom scores versus placebo.
1,400 mg
intravenous dose three times weekly for four weeks
The detail
In a randomized, double-blind pilot trial, 21 people with Parkinson disease whose motor symptoms were not adequately controlled on their existing regimen received intravenous glutathione 1,400 mg or placebo three times weekly for four weeks. Glutathione was well tolerated, reported adverse events were similar in the two groups, and there were no significant differences in changes in Unified Parkinson Disease Rating Scale scores.4
A single oral dose did not raise plasma glutathione over 270 minutes.
3 grams
single oral dose, read as negligible systemic availability
The detail
In 7 healthy volunteers given a single oral dose of glutathione of 0.15 mmol per kilogram, approximately 3 grams, plasma glutathione, cysteine and glutamate did not increase significantly over the following 270 minutes, a result the investigators attributed to hydrolysis by intestinal and hepatic gamma-glutamyltransferase and interpreted as negligible systemic availability of oral glutathione.5
Oral glutathione raised levels 30 to 35 percent, and they returned to baseline after washout.
30 to 35 percent
rise in erythrocytes, plasma and lymphocytes on 1,000 mg per day
The detail
In a six-month randomized, double-blind, placebo-controlled trial, 54 non-smoking adults took oral glutathione at 250 mg or 1,000 mg per day. At six months the 1,000 mg group showed glutathione increases of 30 to 35 percent in erythrocytes, plasma and lymphocytes, and levels returned to baseline after a one-month washout.6
What it does not show
No glutathione product is FDA-approved for antioxidant support, healthy aging or detoxification.
The detail
No glutathione product is approved by the FDA for antioxidant support, healthy aging, detoxification or any of the other reasons people ask about it, and no intranasal glutathione product is FDA-approved for any indication.7
A compounded glutathione nasal spray is not an FDA-approved drug product.
The detail
A compounded glutathione nasal spray is not an FDA-approved drug product. It is prepared to an individual prescription by a licensed pharmacy, and the FDA states that it does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.8
Every intranasal trial was in Parkinson disease; none measured longevity, energy or immune function.
The intranasal evidence is small, short and narrow, and all of it came from one research group.
45 participants
largest randomized intranasal trial, run for three months
Neither intranasal dose separated from placebo, and a brain measurement is not a clinical outcome.
The detail
The one randomized trial designed to evaluate symptomatic relief did not separate either intranasal dose from placebo, no trial has compared intranasal glutathione against injectable or oral glutathione, and showing that an intranasal dose raises glutathione in brain tissue is a biochemical measurement rather than evidence of a clinical outcome.23
- Mischley LK, Leverenz JB, Lau RC, et al. A randomized, double-blind phase I/IIa study of intranasal glutathione… Mov Disord. 2015.
- Mischley LK, Lau RC, Shankland EG, Wilbur TK, Padowski JM. Phase IIb study of intranasal glutathione in Parkinson's disease. J Parkinsons Dis. 2017.
- Mischley LK, Conley KE, Shankland EG, et al. Central nervous system uptake of intranasal glutathione in Parkinson's… NPJ Parkinsons Dis. 2016.
- Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D. Randomized, double-blind, pilot evaluation of intravenous glutathione… Mov Disord. 2009.
- Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992.
- Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body… Eur J Nutr. 2015.
- Drugs@FDA, the FDA database of approved drug products, searched for glutathione as an active ingredient on 11 August 2026; the only approved applications are surgical irrigating solutions, and no nasal, injectable or oral glutathione drug product is approved.FDA
- Compounding and the FDA: Questions and Answers U.S Food and Drug…FDA
Important Safety Information
Do not use if you have
- Asthma and reactive airway disease are screened, alongside active sinus infection, recent nasal surgery and nasal polyps
Serious risks
- One participant on the higher dose in a three-month trial developed tachycardia and a newly diagnosed cardiomyopathy and withdrew
- Nebulized glutathione has been shown to narrow the airways in people with mild asthma, which is a different route from a spray
Commonly reported
- Sinus irritation and headache were the local complaints in the published trials of intranasal glutathione
- Adverse event rates did not separate from placebo
Because it is a nasal spray
- Glutathione has a mild sulfur smell, which is more noticeable with a nasal spray
The investigators could not establish whether the medicine was responsible, and recommended that future studies screen for cardiac effects. Human safety data for compounded intranasal glutathione is limited, which is the reason this sits with a clinician rather than in a shopping cart.
Questions
Asked and answered.
Explore
More in Longevity.
METABOLIC
Semaglutide + B12 Microdose
A lower-dose compounded semaglutide and vitamin B12 injection, with individual prescribing, pharmacy fulfillment and follow-up.
From $109/mo
METABOLIC
Tirzepatide + B12 Microdose
A lower-dose compounded tirzepatide and vitamin B12 injection, with individual prescribing, pharmacy fulfillment and follow-up.
From $149/mo
